# 20 Novo-Passit Solution for oral administration t / s, 100 ml

Novo-Passit solution for oral administration of fl.

t / s 100ml

Name ENG

NOVO-PASSIT

Clinical and pharmacological group

Sedative

ATX code

Other hypnotics and sedatives

Dosage

4g / 100ml + 7.75g / 100ml x 100ml

Structure

Composition per 100 ml of the preparation: active ingredients: Novo-Passita liquid extract (obtained from rhizomes with roots of valerian officinalis, herb of lemon balm, herb St. black elderberry flowers) 7.75 g

guaifenesin 4.00 g

excipients: sodium cyclamate 0.50 g, xanthan gum 0.10 g, invert sugar syrup 39.73 g, sodium benzoate 0.35 g, sodium saccharin mono-hydrate 0.0926 g, ethanol 96% 7.03 g, orange flavor 0.05 g, sodium citrate dihydrate 0.40 g, malto-dextrin 8.00 g, propylene glycol 10.00 g, purified water to 100 ml.

Indications

Neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, distraction.

Manager's syndrome" (a state of constant mental stress).

Insomnia (mild forms).

Headaches due to nervous tension.

Migraine.

Functional diseases of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome).

As a symptomatic remedy for neurocirculatory dystonia and climacteric syndrome.

Itchy dermatoses (atopic and seborrheic eczema, urticaria) caused by psychological stress.

Storage conditions and periods

In a dark place at a temperature of 10-25 degrees.

Shelf life: 4 years - vials

2 years - sachet

INN / Active ingredient

Guaifenesin + novo-passita extract liquid

Contraindications

Hypersensitivity to the components of the drug, especially to guaifenesin.

myasthenia gravis, children under 12 years of age.

With care: acute diseases of the gastrointestinal tract, liver disease, alcoholism, diseases or trauma of the brain, epilepsy.

Use during pregnancy and lactation During pregnancy, the drug is prescribed only for absolute indications, if the expected effect for the mother outweighs the possible risk for the fetus.

If it is necessary to use the drug during lactation, breastfeeding should be discontinued.

Specifications

Category

Sedatives

,

Antipsychotics

,

Neurological disorders

Scope of the drug

Neurology, psychiatry

Release form

Solution

Manufacturer country

Czech

Package quantity, pcs

one

Scope of application

Neurology

Minimum age from

12 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Volume, ml.

100 ml

Brand name

Novo-Passit

Components

measuring cap

The amount of the dosage form in the primary package

100 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Herbal sedative

Anatomical and therapeutic characteristics

N05CM Other hypnotics and sedatives

Dosage form

Oral solution

Packaging

Box

The target audience

Children

Expiration date in days

1461

Package weight, g

2

Mode of application

:

The drug is taken undiluted or diluted in a little water.

When using a bottle, the dosage of the drug is carried out using a measuring cap.

Inside, adults and children over 12 years old. < br> In the absence of other doctor's recommendations, the drug should be taken 5 ml 3 times a day before meals.

After consulting a doctor, it is possible to increase the dose to 10 ml 3 times a day.

If severe fatigue or depression appears, it is necessary to reduce the morning and afternoon dose by 2 times and take 2.5 ml in the morning and afternoon and 5 ml in the evening.

The interval between doses should be 4-6 hours.

In case of nausea, the drug should be taken with food. < br> < br> < br>

Dosage (volume) of the substance in the preparation

:

5 ml: Novo-Passit liquid extract (obtained from rhizomes with roots of Valerian officinalis, herb of lemon balm, herb St. John's wort, leaves and flowers of hawthorn or prickly hawthorn, passionflower herb (passionflower), common hop fruit, 387.5 mg of black elderberry) , guaifenesin 200 mg

"